| Particulars |
|
|
|
| Company Name
| Mankind Pharma Ltd
| Year End
| 202503
|
| Full Year |
| Equity (₹ Cr.) |
41.28 |
B.V. (₹) |
375.70 |
| Sales(₹ Cr.) |
9,497.80 |
NP (₹ Cr.) |
1,691.18 |
| NP Var% |
-1.00 |
Div% |
0.00 |
| CPS(₹) |
50.10 |
EPS (₹) |
41.00 |
| Traded Value(₹ Lakhs) |
166.97 |
52 Week High |
3,050.00 |
| 52 Week Low |
2,116.00 |
Price BSE |
2,180.00 |
| Price NSE |
2,179.00 |
Market Capital (₹ Cr.) |
89,972.93 |
| P/C Ratio |
43.50 |
P/E Ratio |
53.20 |
| Price Vs.BV |
5.80 |
|
| Latest Quarter |
| Year End |
202509 |
Sales (₹ Cr.) |
2,608.78 |
| NP(₹ Cr.) |
458.90 |
NP Var % |
-25.00 |
| Trailing Twelve Months |
| Year End |
202509 |
Sales |
9,288.12 |
| OPM |
26.30 |
NP |
2,004.35 |
| NP Var% |
-16.56 |
EPS |
40.36 |
| PE |
54.00 |
|
|